BIONEXUS GENE LAB CORP (BGLC) Stock News

USA - NASDAQ:BGLC - US0906283066 - Common Stock

4.57 USD

-0.27 (-5.58%)

Last: 11/13/2025, 2:09:56 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BGLC Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Stocktwits

BGLC Stock Tumbled Over 13% Today: Why Is VitaGuard Commercialization Agreement Drawing Investor Attention?

a day ago - By: BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization

3 days ago - By: BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities

10 days ago - By: Benzinga - Mentions: MGN TGE NCRA IPDN ...

12 Industrials Stocks Moving In Monday's Pre-Market Session

24 days ago - By: BioNexus Gene Lab Corp.

News Image

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

3 months ago - By: Benzinga

What's Driving the Market Sentiment Around BioNexus Gene Lab?

24 days ago - By: BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

4 months ago - By: BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology